Akèy › Migrèn › Tennessee › Nashville
Etid klinik pou Migrèn nan Nashville, TN
6 etid pou Migrèn ap chèche patisipan nan sit nan ak bò kote Nashville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study of EVO756 in Adults With Migraine
Ap rekriteFaz 2
- Campbell Clinical Research, Franklin · 17 mi lwen
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Ap rekriteFaz 3
- Access Clinical Trials Inc /ID# 270280, Nashville
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Ap rekriteFaz 4
- Vanderbilt Medical Center, Nashville
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Ap rekriteFaz 3
- Access Clinical Trials, Inc. /ID# 228002, Nashville
Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
Ap rekriteFaz 2
- Clinical Research Associates, Inc., Nashville
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Ap rekriteFaz 3
- Access Clinical Trials, Inc, Nashville
- Clinical Research Associates, Inc., Nashville
Etid Migrèn nan lòt vil
- Cincinnati, OH11 etid
- Philadelphia, PA8 etid
- Concord, CA8 etid
- Austin, TX8 etid
- Miami, FL8 etid
- Amherst, NY7 etid
- Houston, TX7 etid
- Washington, DC7 etid
- Omaha, NE7 etid
- Aurora, CO6 etid
- New York City, NY6 etid
- Portland, OR6 etid
Lòt etid nan Nashville
- Kansè Poumon ki pa ti selil97 etid
- Kansè nan tete81 etid
- Kansè Metastatik70 etid
- Kansè kolorektal69 etid
- Kansè (tout kalite)65 etid
- Kansè ovè49 etid
- Kansè pwostat43 etid
- Kansè poumon40 etid
- Karsinòm selil skuamèz tèt ak kou39 etid
- Kansè pankreyas39 etid
- Kansè Endomèt38 etid
- Melanom33 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.